AVXL

AVXL Operating Cash Flow (Statement)

-$33.73MTTM · USD

Period ending:

AVXL FY Cash from OperationsUSD
AVXL FY Cash from Operations2004-09-30: -$11.89K2005-09-30: -$61.07K2006-09-30: -$32.43K2007-09-30: -$325.25K2008-09-30: -$2.47M2009-09-30: -$2.79M2010-09-30: -$4.59M2011-09-30: -$3.80M2012-09-30: -$1.69M2013-09-30: -$777.57K2014-09-30: -$2.66M2015-09-30: -$4.23M2016-09-30: -$9.24M2017-09-30: -$9.02M2018-09-30: -$12.58M2019-09-30: -$18.53M2020-09-30: -$21.29M2021-09-30: -$30.38M2022-09-30: -$24.24M2023-09-30: -$27.79M2024-09-30: -$30.81M2025-09-30: -$39.04M$0.00-$39.04M
2004-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AVXL operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 22 observations from Sep 30, 2004 to Sep 30, 2025.

Anavex Life Sciences Corp Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-39,044,000
-30,812,000
-27,785,000
-24,238,000
-30,384,000
-21,287,046
-18,527,117
-12,582,406
-9,017,231
-9,236,823
-4,227,006
-2,659,379
-777,573
-1,692,940
-3,801,479
-4,593,588
-2,794,655
-2,474,053
-325,250
-32,428
-61,072
-11,890

Compare operating cash flow (statement)

All AVXL financial metrics · AVXL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.